Suppr超能文献

中药关键药材川芎的药学活性评价

Evaluation of the Pharmaceutical Activities of Chuanxiong, a Key Medicinal Material in Traditional Chinese Medicine.

作者信息

Huang Shiwei, Chen Jiamei, Liu Xiaohua, Xing Chunxin, Zhao Lu, Chan Kelvin, Lu Guanghua

机构信息

State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.

Research Institute of Chinese Medicines as Drug & Food, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.

出版信息

Pharmaceuticals (Basel). 2024 Aug 31;17(9):1157. doi: 10.3390/ph17091157.

Abstract

Szechwan lovage rhizome (, the rhizome of Hort., in Chinese transliteration) is one Chinese materia medica (CMM) commonly used to activate blood circulation and remove blood stasis. SLR is applicable to most blood stasis syndromes. It has significant clinical efficacy in relation to human diseases of the cardiocerebrovascular system, nervous system, respiratory system, digestive system, urinary system, etc. Apart from China, SLR is also used in Singapore, Malaysia, the European Union, and the United States of America. However, the current chemical markers in pharmacopeia or monography for the quality assessment of SLR are not well characterized or specifically characterized, nor do they fully reflect the medicinal efficacy of SLR, resulting in the quality of SLR not being effectively controlled. CMM can only have medicinal efficacy when they are applied in vivo to an organism. The intensity of their pharmaceutical activities can more directly represent the quality of CMM. Therefore, the chemical constituents and pharmacological actions of SLR are reviewed in this paper. In order to demonstrate the medicinal efficacy of SLR in promoting blood circulation and removing blood stasis, bioassay methods are put forward to evaluate the pharmaceutical activities of SLR to improve hemorheology, hemodynamics, and vascular microcirculation, as well as its anti-platelet aggregation and anticoagulation properties. Through comprehensive analyses of these pharmaceutical properties, the quality and therapeutic value of SLR are ascertained.

摘要

川芎(Ligusticum chuanxiong Hort.,中文音译)是一种常用的活血化瘀的中药材。川芎适用于大多数血瘀证。它在人类的心脑血管系统、神经系统、呼吸系统、消化系统、泌尿系统等疾病方面具有显著的临床疗效。除中国外,川芎在新加坡、马来西亚、欧盟和美国也有使用。然而,目前药典或专论中用于川芎质量评估的化学标志物尚未得到充分表征或特异性表征,也不能完全反映川芎的药效,导致川芎的质量无法得到有效控制。中药材只有在体内应用于生物体时才会具有药效。其药理活性的强度能更直接地代表中药材的质量。因此,本文对川芎的化学成分和药理作用进行了综述。为了证明川芎活血化瘀的药效,提出了生物测定方法来评估川芎改善血液流变学、血液动力学和血管微循环以及其抗血小板聚集和抗凝特性的药理活性。通过对这些药理特性的综合分析,确定川芎的质量和治疗价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af96/11434844/43f7f7957cb7/pharmaceuticals-17-01157-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验